Showing results (101-110 of 142) with videos related to
Sort By:
Pageof 15
Journal of Diabetes Investigation|May 5, 2017
Advanced breast cancer in a relatively young man with severe obesity and type 2 diabetes mellitusAtsushi Obata, Seizo Okauchi, Tomohiko Kimura, et al.Endocrine Journal|July 2, 2025
Development of a prediction model by combining tumor diameter and clinical parameters of adrenal incidentalomaYuichiro Iwamoto, Tomohiko Kimura, Yuichi Morimoto, et al.Journal of Medical Case Reports|May 1, 2019
Idiopathic and isolated adrenocorticotropic hormone deficiency presenting as continuous epigastric discomfort without symptoms of hypoglycemia: a case reportSeizo Okauchi, Fuminori Tatsumi, Yuki Kan, et al.Endocrine Journal|May 10, 2026
Overlap syndrome between sarcoidosis and Sjögren's disease presenting as hypopituitarism: case report and review of literatureYuichiro Iwamoto, Noriko Yoshimura, Ayaka Harada, et al.Springerplus|November 22, 2016
Dramatic mitigation of bone pain after phosphorus replacement therapy in a subject with FGF23-related hypophosphatemic osteomalaciaFuminori Tatsumi, Megumi Horiya, Akihito Tanabe, et al.Journal of Diabetes Research|March 7, 2018
Effect of Tofogliflozin on Body Composition and Glycemic Control in Japanese Subjects with Type 2 Diabetes MellitusShinji Kamei, Masahiro Iwamoto, Miyuki Kameyama, et al.Diabetes, Obesity & Metabolism|March 20, 2024
Dipeptidyl peptidase-4 inhibitor and sodium-glucose cotransporter 2 inhibitor additively ameliorate hepatic steatosis through different mechanisms of action in high-fat diet-fed miceYuichiro Iwamoto, Tomohiko Kimura, Kazunori Dan, et al.Scientific Reports|August 17, 2023
Simple standing test without furosemide is useful in the diagnosis of primary aldosteronismYuichiro Iwamoto, Tomohiko Kimura, Mana Ohnishi, et al.Journal of Diabetes Research|January 15, 2024
Usefulness of Once-Weekly GLP-1 Receptor Agonist Semaglutide on Glycemic Control in Subjects with Type 2 Diabetes Mellitus: Switching from the Same Class Dulaglutide in a Retrospective Observation StudyTomohiko Kimura, Masato Kubo, Kaio Takahashi, et al.Diabetes, Obesity & Metabolism|September 30, 2024
Tirzepatide, a dual glucose-dependent insulinotropic polypeptide/glucagon-like peptide 1 receptor agonist, exhibits favourable effects on pancreatic β-cells and hepatic steatosis in obese type 2 diabetic db/db miceYuichiro Iwamoto, Tomohiko Kimura, Kazunori Dan, et al.Pageof 15